Brief: Control Bionics Says FY Loss Attributable A$5.6 Mln
31/08/2023 02:56
Aug 31 (Reuters) - Control Bionics Ltd CBL.AX :
* FY LOSS ATTRIBUTABLE A$5.6 MILLION
* FY REVENUES FROM ORDINARY ACTIVITIES UP 25.3% TO A$5.6
MILLION
Source text for Eikon: ID:nASX579VMb
Further company coverage: CBL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device